# Centerpoint Energy Inc: financial statements, quarterly

CNP · NYSE · CIK 1130310 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cnp.md) · [Financials](/companies/cnp/financials.md) · [Filings](/companies/cnp/filings.md) · [Insiders](/companies/cnp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cnp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,872](/filings/0001130310-24-000093.md) | [1,864](/filings/0001130310-24-000115.md) | [2,115 d](/filings/0001130310-26-000008.md) | [2,594](/filings/0001130310-25-000079.md) | [1,906](/filings/0001130310-25-000113.md) | [1,849](/filings/0001130310-25-000143.md) | [2,203 d](/filings/0001130310-26-000008.md) | [2,956](/filings/0001130310-26-000028.md) | [1,953](/filings/0001130310-25-000113.md) | [1,990](/filings/0001130310-25-000143.md) | [2,438 d](/filings/0001130310-26-000008.md) | [2,975](/filings/0001130310-26-000028.md) |
| Cost of revenue | $m | [57.0](/filings/0001130310-24-000093.md) | [1.0](/filings/0001130310-24-000115.md) | [1.0 d](/filings/0001130310-26-000008.md) | [1.0](/filings/0001130310-25-000079.md) | [0.0](/filings/0001130310-25-000113.md) | [1.0](/filings/0001130310-25-000143.md) | [1.0 d](/filings/0001130310-26-000008.md) | [1.0](/filings/0001130310-26-000028.md) | [2.0](/filings/0001130310-25-000113.md) | [1.0](/filings/0001130310-25-000143.md) | [0.0 d](/filings/0001130310-26-000008.md) | [1.0](/filings/0001130310-26-000028.md) |
| Operating income | $m | [380](/filings/0001130310-24-000093.md) | [518](/filings/0001130310-24-000115.md) | [321 d](/filings/0001130310-26-000008.md) | [616](/filings/0001130310-25-000079.md) | [467](/filings/0001130310-25-000113.md) | [424](/filings/0001130310-25-000143.md) | [483 d](/filings/0001130310-26-000008.md) | [649](/filings/0001130310-26-000028.md) | [417](/filings/0001130310-25-000113.md) | [502](/filings/0001130310-25-000143.md) | [542 d](/filings/0001130310-26-000008.md) | [658](/filings/0001130310-26-000028.md) |
| Interest expense | $m | not reported | not reported | not reported | [204](/filings/0001130310-25-000079.md) | [217](/filings/0001130310-25-000113.md) | [195](/filings/0001130310-25-000143.md) | [222 d](/filings/0001130310-26-000008.md) | [238](/filings/0001130310-26-000028.md) | [195](/filings/0001130310-25-000113.md) | [243](/filings/0001130310-25-000143.md) | [227 d](/filings/0001130310-26-000008.md) | [279](/filings/0001130310-26-000028.md) |
| Income tax | $m | [99.0](/filings/0001130310-24-000093.md) | [68.0](/filings/0001130310-24-000115.md) | [(75.0) d](/filings/0001130310-26-000008.md) | [78.0](/filings/0001130310-25-000079.md) | [33.0](/filings/0001130310-25-000113.md) | [52.0](/filings/0001130310-25-000143.md) | [32.0 d](/filings/0001130310-26-000008.md) | [81.0](/filings/0001130310-26-000028.md) | [55.0](/filings/0001130310-25-000113.md) | [(7.0)](/filings/0001130310-25-000143.md) | [66.0 d](/filings/0001130310-26-000008.md) | [93.0](/filings/0001130310-26-000028.md) |
| Net income | $m | [118](/filings/0001130310-24-000093.md) | [282](/filings/0001130310-24-000115.md) | [192 d](/filings/0001130310-26-000008.md) | [350](/filings/0001130310-25-000079.md) | [228](/filings/0001130310-25-000113.md) | [193](/filings/0001130310-25-000143.md) | [248 d](/filings/0001130310-26-000008.md) | [297](/filings/0001130310-26-000028.md) | [198](/filings/0001130310-25-000113.md) | [293](/filings/0001130310-25-000143.md) | [264 d](/filings/0001130310-26-000008.md) | [316](/filings/0001130310-26-000028.md) |
| Diluted EPS | $ per share | [0.17](/filings/0001130310-24-000093.md) | [0.40](/filings/0001130310-24-000115.md) | not reported | [0.55](/filings/0001130310-25-000079.md) | [0.36](/filings/0001130310-25-000113.md) | [0.30](/filings/0001130310-25-000143.md) | not reported | [0.45](/filings/0001130310-26-000028.md) | [0.30](/filings/0001130310-25-000113.md) | [0.45](/filings/0001130310-25-000143.md) | not reported | [0.48](/filings/0001130310-26-000028.md) |
| Basic EPS | $ per share | [0.17](/filings/0001130310-24-000093.md) | [0.41](/filings/0001130310-24-000115.md) | not reported | [0.55](/filings/0001130310-25-000079.md) | [0.36](/filings/0001130310-25-000113.md) | [0.30](/filings/0001130310-25-000143.md) | not reported | [0.45](/filings/0001130310-26-000028.md) | [0.30](/filings/0001130310-25-000113.md) | [0.45](/filings/0001130310-25-000143.md) | not reported | [0.48](/filings/0001130310-26-000028.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.2](/filings/0001130310-23-000110.md) | [0.1](/filings/0001130310-23-000146.md) | [0.1](/filings/0001130310-25-000040.md) | [0.2](/filings/0001130310-24-000066.md) | [0.1](/filings/0001130310-24-000093.md) | [0.1](/filings/0001130310-24-000115.md) | [0.0](/filings/0001130310-26-000008.md) | [1.3](/filings/0001130310-25-000079.md) | [0.1](/filings/0001130310-25-000113.md) | [0.0](/filings/0001130310-25-000143.md) | [0.0](/filings/0001130310-26-000028.md) | [0.6](/filings/0001130310-26-000028.md) |
| Current assets | $bn | [2.8](/filings/0001130310-23-000110.md) | [3.0](/filings/0001130310-23-000146.md) | [3.0](/filings/0001130310-25-000040.md) | [4.3](/filings/0001130310-24-000066.md) | [4.1](/filings/0001130310-24-000093.md) | [4.3](/filings/0001130310-24-000115.md) | [4.4](/filings/0001130310-26-000008.md) | [4.1](/filings/0001130310-25-000079.md) | [2.9](/filings/0001130310-25-000113.md) | [2.9](/filings/0001130310-25-000143.md) | [5.7](/filings/0001130310-26-000028.md) | [6.2](/filings/0001130310-26-000028.md) |
| Total assets | $bn | [38.1](/filings/0001130310-23-000110.md) | [39.0](/filings/0001130310-23-000146.md) | [39.7](/filings/0001130310-25-000040.md) | [40.2](/filings/0001130310-24-000066.md) | [41.0](/filings/0001130310-24-000093.md) | [42.9](/filings/0001130310-24-000115.md) | [43.8](/filings/0001130310-26-000008.md) | [44.5](/filings/0001130310-25-000079.md) | [44.1](/filings/0001130310-25-000113.md) | [45.0](/filings/0001130310-25-000143.md) | [46.5](/filings/0001130310-26-000028.md) | [47.8](/filings/0001130310-26-000028.md) |
| Current liabilities | $bn | [3.2](/filings/0001130310-23-000110.md) | [3.9](/filings/0001130310-23-000146.md) | [3.9](/filings/0001130310-25-000040.md) | [3.4](/filings/0001130310-24-000066.md) | [3.4](/filings/0001130310-24-000093.md) | [3.8](/filings/0001130310-24-000115.md) | [4.0](/filings/0001130310-26-000008.md) | [4.4](/filings/0001130310-25-000079.md) | [3.7](/filings/0001130310-25-000113.md) | [5.7](/filings/0001130310-25-000143.md) | [6.3](/filings/0001130310-26-000028.md) | [5.3](/filings/0001130310-26-000028.md) |
| Long-term debt | $bn | [16.0](/filings/0001130310-23-000110.md) | [16.8](/filings/0001130310-23-000146.md) | [17.6](/filings/0001130310-25-000040.md) | [18.1](/filings/0001130310-24-000066.md) | [18.5](/filings/0001130310-24-000093.md) | [19.7](/filings/0001130310-24-000115.md) | [20.4](/filings/0001130310-26-000008.md) | [20.4](/filings/0001130310-25-000079.md) | [20.6](/filings/0001130310-25-000113.md) | [19.4](/filings/0001130310-25-000143.md) | [20.6](/filings/0001130310-26-000028.md) | [22.5](/filings/0001130310-26-000028.md) |
| Current portion of debt | $bn | not reported | not reported | [1.1](/filings/0001130310-25-000040.md) | not reported | not reported | not reported | [0.6](/filings/0001130310-26-000008.md) | not reported | not reported | not reported | [2.4](/filings/0001130310-26-000008.md) | not reported |
| Short-term borrowings | $bn | [0.0](/filings/0001130310-23-000110.md) | [0.0](/filings/0001130310-23-000146.md) | [0.0](/filings/0001130310-25-000040.md) | [0.0](/filings/0001130310-24-000066.md) | [0.0](/filings/0001130310-24-000093.md) | [0.0](/filings/0001130310-24-000115.md) | [0.5](/filings/0001130310-26-000008.md) | [0.5](/filings/0001130310-25-000079.md) | [0.5](/filings/0001130310-25-000113.md) | [0.5](/filings/0001130310-25-000143.md) | [0.5](/filings/0001130310-26-000028.md) | [0.0](/filings/0001130310-26-000028.md) |
| Shareholders' equity | $bn | [10.4](/filings/0001130310-24-000093.md) | [9.6](/filings/0001130310-24-000115.md) | [9.7](/filings/0001130310-26-000008.md) | [10.0](/filings/0001130310-25-000079.md) | [10.4](/filings/0001130310-25-000113.md) | [10.5](/filings/0001130310-25-000143.md) | [10.7](/filings/0001130310-26-000008.md) | [11.0](/filings/0001130310-26-000028.md) | [11.0](/filings/0001130310-25-000113.md) | [11.0](/filings/0001130310-25-000143.md) | [11.2](/filings/0001130310-26-000028.md) | [11.4](/filings/0001130310-26-000028.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:DebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [769 d](/filings/0001130310-24-000093.md) | [587 d](/filings/0001130310-24-000115.md) | [808 d](/filings/0001130310-26-000008.md) | [538](/filings/0001130310-25-000079.md) | [576 d](/filings/0001130310-25-000113.md) | [136 d](/filings/0001130310-25-000143.md) | [889 d](/filings/0001130310-26-000008.md) | [410](/filings/0001130310-26-000028.md) | [560 d](/filings/0001130310-25-000113.md) | [742 d](/filings/0001130310-25-000143.md) | [774 d](/filings/0001130310-26-000008.md) | [282](/filings/0001130310-26-000028.md) |
| Capital expenditure | $m | [1,136 d](/filings/0001130310-24-000093.md) | [1,064 d](/filings/0001130310-24-000115.md) | [1,078 d](/filings/0001130310-26-000008.md) | [845](/filings/0001130310-25-000079.md) | [812 d](/filings/0001130310-25-000113.md) | [844 d](/filings/0001130310-25-000143.md) | [2,012 d](/filings/0001130310-26-000008.md) | [1,038](/filings/0001130310-26-000028.md) | [1,129 d](/filings/0001130310-25-000113.md) | [1,222 d](/filings/0001130310-25-000143.md) | [1,481 d](/filings/0001130310-26-000008.md) | [1,198](/filings/0001130310-26-000028.md) |
| Dividends paid | $m | [120 d](/filings/0001130310-24-000093.md) | [119 d](/filings/0001130310-24-000115.md) | [126 d](/filings/0001130310-26-000008.md) | [126](/filings/0001130310-25-000079.md) | [128 d](/filings/0001130310-25-000113.md) | [130 d](/filings/0001130310-25-000143.md) | [138 d](/filings/0001130310-26-000008.md) | [143](/filings/0001130310-26-000028.md) | [144 d](/filings/0001130310-25-000113.md) | [144 d](/filings/0001130310-25-000143.md) | [143 d](/filings/0001130310-26-000008.md) | [150](/filings/0001130310-26-000028.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets, us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [632](/filings/0001130310-23-000110.md) | [633](/filings/0001130310-23-000146.md) | [633](/filings/0001130310-24-000066.md) | [633](/filings/0001130310-24-000093.md) | [633](/filings/0001130310-24-000115.md) | [634](/filings/0001130310-25-000079.md) | [642](/filings/0001130310-25-000113.md) | [648](/filings/0001130310-25-000143.md) | [653](/filings/0001130310-26-000028.md) | [654](/filings/0001130310-25-000113.md) | [656](/filings/0001130310-25-000143.md) | [659](/filings/0001130310-26-000028.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 654,169,480 at 2026-04-15, from the cover of the [10-Q filed 2026-04-23](/filings/0001130310-26-000028.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 27, 2026, 06:13 ET. No prices; not investment advice.